EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Renal Involvement in Leprosy in the Multidrug Therapy Era: Current Evidence and Clinical Monitoring

Kleberson de Oliveira, Lucas Maciel de Almeida Corrêa, Luiggi Kevin Virgino Brandão, Isabela Malerba Pinheiro, Nilson Hitoshi Yoshimoto, Maria Clara do Nascimento Meneses, Rodrigo Anselmo Cazzaniga, Carlo José Freire de Oliveira

Current Tropical Medicine Reports · 07.07.2026 · 13 (1)

DOI: 10.1007/s40475-026-00372-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Tropical Medicine Reports, online erschienen am 07.07.2026. Verfasst von Kleberson de Oliveira und 7 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Faculdade De Medicina De São José Do Rio Preto.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose of Review Leprosy remains a contemporary tropical-medicine challenge in which systemic complications may be overlooked when follow-up is centered on skin lesions, peripheral nerves, and completion of multidrug therapy (MDT). This review synthesizes historical and MDT-era evidence on renal involvement in leprosy and reframes kidney assessment as a practical complication-monitoring issue for infectious-disease care. Recent Findings Classical clinicopathologic studies established that leprosy may be associated with glomerular disease, tubulointerstitial injury, and amyloid A amyloidosis, particularly in multibacillary or lepromatous disease with recurrent erythema nodosum leprosum (ENL). In the MDT era, severe nephropathy appears less dominant, whereas renal involvement may be expressed through milder, dynamic, and context-dependent abnormalities, including albuminuria or proteinuria, microscopic hematuria, mild creatinine elevation, estimated glomerular filtration rate decline, and investigational inflammatory or endothelial signals such as MCP-1 and VCAM-1. These findings should be interpreted probabilistically, because bacillary burden, reactional inflammation, delayed diagnosis, hypertension, nephrotoxic exposure, dehydration, sepsis, and rifampicin-associated acute kidney injury may coexist. Summary Renal monitoring in leprosy should prioritize risk-enriched patients, including those with multibacillary disease, ENL or recurrent reactions, delayed diagnosis, abnormal urinalysis, hypertension, nephrotoxic exposure, or rising creatinine. Conventional assessment with serum creatinine, estimated glomerular filtration rate, urinalysis with microscopy, and albuminuria or proteinuria testing may help identify patients who require repeat evaluation, broader differential work-up, or nephrology referral. The proposed approach is a pragmatic synthesis for risk-based clinical reasoning, not a validated guideline or prognostic score.

Förderung

  • Faculdade De Medicina De São José Do Rio Preto

Zitieren

APA

Oliveira, K. D., Corrêa, L. M. D. A., Brandão, L. K. V., Pinheiro, I. M., Yoshimoto, N. H., Meneses, M. C. D. N., Cazzaniga, R. A., & Oliveira, C. J. F. D. (2026). Renal Involvement in Leprosy in the Multidrug Therapy Era: Current Evidence and Clinical Monitoring. Current Tropical Medicine Reports, 13(1). https://doi.org/10.1007/s40475-026-00372-8

Vancouver

Oliveira KD, Corrêa LMDA, Brandão LKV, Pinheiro IM, Yoshimoto NH, Meneses MCDN, et al. Renal Involvement in Leprosy in the Multidrug Therapy Era: Current Evidence and Clinical Monitoring. Current Tropical Medicine Reports. 2026;13(1). doi:10.1007/s40475-026-00372-8

BibTeX
@article{Oliveira2026,
  author = {Oliveira, Kleberson de and Corrêa, Lucas Maciel de Almeida and Brandão, Luiggi Kevin Virgino and Pinheiro, Isabela Malerba and Yoshimoto, Nilson Hitoshi and Meneses, Maria Clara do Nascimento and Cazzaniga, Rodrigo Anselmo and Oliveira, Carlo José Freire de},
  title = {Renal Involvement in Leprosy in the Multidrug Therapy Era: Current Evidence and Clinical Monitoring},
  journal = {Current Tropical Medicine Reports},
  year = {2026},
  volume = {13},
  number = {1},
  doi = {10.1007/s40475-026-00372-8}
}
Kostenlos starten →